Due to the ever-increasing burden that cognitive dysfunctions have taken on in HD patients and the lack of effective drug treatments, the aim of this study is to investigate the impact of ADAM10 inhibition strategies on morphological, molecular, and functional defects of the HD hippocampus. Here, ADAM10 is linked to Huntington disease.